Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples